Successful Management of Sickle Cell Disease Patient with Covid-19 Infection in a Low Resource Setting: Case Study
Akaba Kingsley, Edu C. Betta, Akaba Edakabasi, Essien Ofonime & Bibia Glory Philemon · Journal of Pharmaceutical Research International · 2021
Background: Sickle cell disease (SCD) patients have greater susceptibility to infections, they are reckoned to be vulnerable patients during the current COVID-19 pandemic. SCD patients are commonly affected by pulmonary complications such as acute chest syndrome (ACS), pulmonary...
Open access
Research Article
10.9734/jpri/2021/v33i26A31475